Advertisement

Abstract

The effects of gonadal hormones on serum lipids have been of great interest to the physician because of the considerably greater vulnerability of men to coronary heart disease in comparison with women, whose lesser vulnerability to coronary artery disease has been, until recently, popularly attributed to a presumed cholesterol-lowering effect of ovarian estrogen.

Keywords

Serum Cholesterol Serum Lipid Serum Lipoprotein Gonadal Hormone Estrogen Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Furman, R.H.: Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease? Ann. New York Acad. Sci. 149:822–833 (1968).CrossRefGoogle Scholar
  2. 2.
    Komerup, V.: Concentrations of cholesterol, total fat and phospholipid in serxim of normal men. Arch. Int. Med. Exp. 85:398–415 (1950).CrossRefGoogle Scholar
  3. 3.
    Peters, J.P. and Van Slyke, D.D.: Quantitative Clinical Chemistry. Interpretations, Vol. 1 (Williams and Wilkins Co., Baltimore, 1946).Google Scholar
  4. 4.
    Block, W.J., Barker, N.W. and Mann, F.D.: Effect of small doses of heparin in increasing the transluscence of plasma during alimentary lipemia. Studies in normal persons and patients having atherosclerosis. Circulation 4:674–678 (1951).PubMedGoogle Scholar
  5. 5.
    Moore, F.E. and Gordon, T.: Serum cholesterol levels of adults. United States 1960–1962, U.S. Department of Health, Education and Welfare, National Center for Health Statistics, Series 11, Number 22, United States Government Printing Office, Washington, D.C. (1967).Google Scholar
  6. 6.
    Oliver, M.F. and Boyd, G.S.: Changes in the plasma lipids during the menstrual cycle. Clin. Sci. 12:217–222 (1953).PubMedGoogle Scholar
  7. 7.
    Adlercreutz, H. and Tallqvist, G.: Variations in the serum total cholesterol and hematocrit values in normal women during the menstrual cycle. Scand. J. Clin. Lab. Invest. 11:1–9 (1959).PubMedCrossRefGoogle Scholar
  8. 8.
    Peters, J.P., Heineman, M. and Man, E.B.: The lipids of serum in pregnancy. J. Clin. Invest 30:388–394 (1951).PubMedCrossRefGoogle Scholar
  9. 9.
    Mann, G.V. and Shaffer, R.D.: Cholesteremia in pregnant Masai women. J. Am. Med. Assoc. 197:1071–1073 (1966).CrossRefGoogle Scholar
  10. 10.
    Adlercreutz, H., Kerstell, J. and Svanborg, A.: Simultaneous estimation of plasma cholesterol, total and individual phospholipids, triglycerides, free fatty acids and Cortisol, and urinary estrogens, total 17-ketosteroids, individual 11-deoxy- 17-ketosteroids and pregnanediol during the menstrual cycle and in early pregnancy. Ann. Med. Exp. Fenn. 45:285–292 (1967).PubMedGoogle Scholar
  11. 11.
    Eilert, M.L.: The effects of estrogens upon the partition of the serum lipids in female patients. Amer. Heart J. 38:472 (1949).Google Scholar
  12. 12.
    Ellert, M.L.: The effect of estrogens upon the partition of the serum lipids in female patients. Metabolism 2: 137–145 (1953).Google Scholar
  13. 13.
    Oliver, M.F. and Boyd, G.S.: The effect of estrogens on the plasmia lipids in coronary artery disease. Amer. Heart J. 47: 348–359 (1954).PubMedCrossRefGoogle Scholar
  14. 14.
    Oliver, M.F. and Boyd, G.S.: The influence of the sex hormones on the circulatory lipids and lipoproteins in coronary sclerosis. Circulation 13:82–91 (1956).PubMedGoogle Scholar
  15. 15.
    Barr, D.P., Russ, E.M. and Eder, H.A.: Influence of estrogens on lipoproteins in atherosclerosis. Trans. Assoc. Amer. Physicians 65: 102–113 (1952).Google Scholar
  16. 16.
    Barr, D.P.: Some chemical factors in the pathogenesis atherosclerosis. Circulation 8: 641–654 (1953).PubMedGoogle Scholar
  17. 17.
    Barr, D.P., Russ, E.M. and Eder, H.A.: Section VII of Blood cells and plasma proteins; in Tullis’ Protein-lipid relationships in plasma, Ch. 4 (Academic Press, New York 1953).Google Scholar
  18. 18.
    Russ, E.M., Eder, H.A. and Barr, D.P.: Influence of gonadal hormones on protein-lipid relationships in human plasma. Amer. J. Med. 19:4–24 (1955).PubMedCrossRefGoogle Scholar
  19. 19.
    Steiner, A., Payson, H. and Kendall, F.E.: Effect of estrogenic hormone on serum lipids in patients with coronary atherosclerosis. Circulation 11:784–788 (1955).PubMedGoogle Scholar
  20. 20.
    Marett, W.C. and Vivas, J.R.: The effect of oral estrogens on serum cholesterol and total lipids. U.S. Armed Forces Med. J. 4: 1439–1448 (1953).PubMedGoogle Scholar
  21. 21.
    Gitman, L. and Greenblatt, I.J.: Effect of intravenously administered estrogen in cardiovascular disease. Angiology 4:502–509 (1953).PubMedCrossRefGoogle Scholar
  22. 22.
    Gertler, M.M., Hudson, P.B. and Jost, H.: Effects of castration and diethylstilbestrol on the serum lipid pattern in man. Geriatrics 8:500–503 (1953).PubMedGoogle Scholar
  23. 23.
    Robinson, R.W., Higano, N., Cohen, W.D., Sniffen, R.C. and Sherer, J.W., Jr.: Effects of estrogen therapy on hormonal functions and serum lipids in men with coronary atherosclerosis. Circulation 14:365–372 (1956).PubMedGoogle Scholar
  24. 24.
    Furman, R.H., Alaupovic, P. and Howard, R.P.: Effects of androgens and estrogens on seriam lipids and the composition and concentration of serum lipoproteins in normolipemic and hyper- lipidemic states. Prog. Biochem. Pharmacol. 2:215–249 (Basel/ New York 1967).Google Scholar
  25. 25.
    Furman, R.H., Howard, R.P., Norcia, L.N. and Keaty, E.G.: The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins. Observations in hypogonadal and normal human subjects. Amer. J. Med. 24: 80–97 (1958).PubMedCrossRefGoogle Scholar
  26. 26.
    Russ, E.M., Eder, H.A. and Barr, D.P.: Protein-lipid relationships in humn plasma. I. In normal individuals. Amer. J. Med. 11: 468–479 (1951).PubMedCrossRefGoogle Scholar
  27. 27.
    Lewis, L.A., Green, A.A. and Page, I.H.: Ultracentri- fuge lipoprotein patterns of serum of normal, hypertensive and hypothyroid animals. Amer. J. Physiol. 171:391–400 (1952).PubMedGoogle Scholar
  28. 28.
    Lewis, L.A., Green, A.A. and Page, I.H.: The alpha and beta lipoprotein pattern of normal and pathological human sera. Fed. Proc. 10:84 (1951).Google Scholar
  29. 29.
    Lewis, L.A. and Page, I.H.: Electrophoretic and ultracentrifugal analysis of serum lipoproteins of normal, nephrotic and hypertensive persons. Circulation 7: 707–717 (1953).PubMedGoogle Scholar
  30. 30.
    Gofman, J.W., Jones, H.B., Lindgren, F.T., Lyon, T.P., Elliott, H.A. and Strisower, B.: Blood lipids and human atherosclerosis. Circulation 2: 161–178 (1950).PubMedGoogle Scholar
  31. 31.
    Havel, R.J., Eder, H.A. and Bragdon, J.H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345–1353 (1955).PubMedCrossRefGoogle Scholar
  32. 32.
    Nikkila, E.: Studies on the lipid-protein relationships in normal and pathological sera and the effect of heparin on serum lipoproteins. Scand. J. Clin. Lab. Invest. (Suppl. 8) 5:1–101 (1953).Google Scholar
  33. 33.
    Antonini, F.M., Piva, G., Salvini, L. and Sordi, A.: Lipoproteine ed eparina nel guardo umorale della chemiopatogenesi dell’arterosclerosi. Gior. Gerontol. (Suppl. 1), 1–96 (1953).Google Scholar
  34. 34.
    Furman, R.H., Howard, R.P. and Imagawa, R.: Serum lipid and lipoprotein concentrations in castrate and noncastrate institutionalized male subjects. Circulation 14:490–491 (1956).Google Scholar
  35. 35.
    Barclay, K., Barclay, R.K., Skipski, V.P., Terebus-Kekish, O., Mueller, E.S. and Elkins, W.L. :Fluctuations in human serum lipoproteins during the normal menstrual cycle. Biochem. J. 96:205–209 (1965).PubMedGoogle Scholar
  36. 36.
    Barr, D.P.: Influence of sex and sex hormones upon the development of atherosclerosis and upon the lipoproteins of plasma. J. Chron. Dis. 1:63–85 (1955).PubMedCrossRefGoogle Scholar
  37. 37.
    Glass, S.J., Engelberg, H., Marcus, R., Jones, H.B. and Gofman, J.: Lack of effect of administered estrogens in the serum lipids and lipoproteins of male and female patients. Metabolism 2: 133–136 (1953).PubMedGoogle Scholar
  38. 38.
    Engelberg, H. and Glass, S.J.: Influence of physiologic doses of sex steroid hormones on serum lipids and lipoproteins in humans. Metabolism 4:298–301 (1955).PubMedGoogle Scholar
  39. 39.
    Oliver, M.F. and Boyd, G.S.: Endocrine aspects of coronary sclerosis. Lancet 2: 1273 (1956).CrossRefGoogle Scholar
  40. 40.
    Howard, R.P. and Furman, R.H.: Metabolic and serum lipid effects of methylandrostane and methylandrostene pyrazoles. J. Clin. Endo. Metab. 22:43–51 (1962).CrossRefGoogle Scholar
  41. 41.
    Furman, R.H., Howard, R.P., Lakshmi, K. and Norcia, L.N.: The serum lipids and lipoproteins in normal and hyperlipidemic subjects as determined by preparative ultracentrifugation. Effects of dietary and therapeutic measures. Changes induced by in vitro exposure of serum to sonic forces. Amer. J. Clin. Nutr. 9: 73–102 (1961).PubMedGoogle Scholar
  42. 42.
    Furman, R.H., Norcia, L.N., Robinson, C.W., Jr. and Gonzalez, I.E.: Influence of testosterone, methyltestosterone and dl-ethionine on canine liver lipids, serum lipids and lipoproteins. Amer. J. Physiology 191:561–572 (1957).Google Scholar
  43. 43.
    Furman, R.H., Robinson, C.W., Jr., Bradford, R.H., Alaupovic, P. and Norcia, L.N.: Methyltestosterone effect on serum cholesterol radioactivity in dogs given C14-acetate. Proc. Soc. Exper. Biol, and Med. 113: 789–794 (1963).Google Scholar
  44. 44.
    Mosbach, E.H., Abell, L.L. and Kendall, F.E.: In Drugs Affecting Lipid Metabolism. Elsevier Publishing Company, The Netherlands, pp. 119–131 (1961).Google Scholar
  45. 45.
    Abell, L.L. and Mosbach, E.H.: Hypocholesterolemic effect of methyltestosterone in rats. J. Lipid Res.3: 88–91 (1962).Google Scholar
  46. 46.
    Raiford, R.L. and Wong, H.Y.C.: In vivo incorporation of acetate-l-C14 into cholesterol and fatty acids following testosterone propionate administration. Circulation Res. 11:752- 757 (1962).Google Scholar
  47. 47.
    Abell, L.L., Mosbach, E.H. and Kendall, F.E.: Influence of diet on the hypocholesterolemic action of methyltestosterone in dogs. J. Nutrition 87: 285–292 (1965).Google Scholar
  48. 48.
    Alaupovic, P., Howard, R.P. and Furman, R.H.: Effect of estrogens and androgens on the alpha and beta lipoprotein composition in human subjects. Circulation 28: 647 (1963).Google Scholar
  49. 49.
    Furman, R.H., Sanbar, S.S., Alaupovic, P., Bradford, R.H and Howard, R.P.: Studies of the metabolism of radioiodinated human serum alpha lipoprotein in normal and hyperlipidemic subjects. J. Lab. Clin. Med. 63: 193–204 (1964).PubMedGoogle Scholar
  50. 50.
    Levy, R.I., Lees, R.S. and Fredrickson, D.S.: A functional role for plasma alphai lipoproteins. J. Clin. Invest. 44:1068 (1965).Google Scholar
  51. 51.
    Furman, R.H., Howard, R.P. and Norcia, L.N.: In Hormones and Atherosclerosis, G. Pincus, Editor, Academic Press, New York, Ch. 25, pp. 349–370 (1958).Google Scholar
  52. 52.
    Furman, R.H., Howard, R.P. and Norcia, L.N.: Modification of the responses of serum lipids, lipoproteins, and urinary creatine excretion to androgen and estrogen administration following isocaloric substitution of carbohydrate for dietary protein. J. Lab. Clin. Med. 52:813–814 (1958).Google Scholar
  53. 53.
    Crider, Q.E., Bradford, R.H. and Furman, R.H.: Effect of methyltestosterone on the protein moiety of canine serum alpha- lipoproteins. Circulation 32 (II):8 (1965).Google Scholar
  54. 54.
    Aurell, M., Cramer, K. and Rybo, G.: Serum lipids and lipoproteins during long term administration of an oral contraceptive. Lancet 1:291–293 (1966).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1969

Authors and Affiliations

  • R. H. Furman
    • 1
  1. 1.Oklahoma Medical Research FoundationThe University of Oklahoma Medical CenterOklahoma CityUSA

Personalised recommendations